Delivery Order SPE2DR25D3301-SPE2DR26F18CS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $32,750.34 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a $10,916.78 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award to support federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 20,000 units of 10ML vials. This is a competitive award with no set-aside designation and completion scheduled for November 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its corporate office location in the...
- The Defense Logistics Agency awarded a $23,009.20 delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products (20,000 units of 10ML vials). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 9, 2025, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials) with an ultimate completion date of October 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $21,833.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This firm fixed-price delivery order, issued on July 24, 2025, with completion targeted for August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and specifies performance at the...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18CSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,504.60 to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG pharmaceutical product, consisting of 20,000 units of 10ML vials. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by December 9, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications and medical supplies to support military healthcare programs worldwide. As a critical vendor for the Defense Health Agency and other federal healthcare systems, AmerisourceBergen leverages this flexible contract framework to fulfill ongoing pharmaceutical requirements across multiple therapeutic domains for the Department of Defense and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 11/17/25 |